VRTX
52
-2
SO
51
-4
BAX
33
-3
BIIB
40
-2
T
53
8
MCO
78
-2
HSIC
56
-3
IVZ
53
-2
NVDA
56
2
DGX
39
2
STI
26
-5
O
20
-2
ES
19
-9
NSC
60
-2
RIG
61
3
NKE
40
-2
PRU
62
-2
FLS
75
3
DD
60
-7
BRK.B
38
-5
VRTX
52
-2
SO
51
-4
BAX
33
-3
BIIB
40
-2
T
53
8
MCO
78
-2
HSIC
56
-3
IVZ
53
-2
NVDA
56
2
DGX
39
2
STI
26
-5
O
20
-2
ES
19
-9
NSC
60
-2
RIG
61
3
NKE
40
-2
PRU
62
-2
FLS
75
3
DD
60
-7
BRK.B
38
-5
Financhill
Back

Janux Therapeutics Vs. Phathom Pharmaceuticals Industry Stock Comparison

Sell
34

JANX
Janux Therapeutics

Last Price:
66.94
Seasonality Move:
133.13%
Sell
27

PHAT
Phathom Pharmaceuticals

Last Price:
8.95
Seasonality Move:
15.03%
Sell
34
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy, Sell or Hold?

  • The current Janux Therapeutics [JANX] share price is $59.86. The Score for JANX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Phathom Pharmaceuticals (PHAT) is a Sell

Is Phathom Pharmaceuticals a Buy, Sell or Hold?

  • The current Phathom Pharmaceuticals [PHAT] share price is $8.84. The Score for PHAT is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • PHAT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JANX Stock Price Chart

What is Janux Therapeutics's stock price today?

  • The Janux Therapeutics share price today is $59.86
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

PHAT Stock Price Chart

What is Phathom Pharmaceuticals's stock price today?

  • The Phathom Pharmaceuticals share price today is $8.84
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAT is experiencing slight selling pressure.

JANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.63 Sell
Relative Strength Index (14 RSI): 63.62 Buy
Chaikin Money Flow: -6955717 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (47.07 - 55.53) Buy
Bollinger Bands (100): (41.63 - 51.75) Buy

PHAT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.88 Sell
Relative Strength Index (14 RSI): 29.67 Sell
Chaikin Money Flow: -156642 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.22 - 16.6) Sell
Bollinger Bands (100): (10.97 - 17.63) Sell

JANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.16 Buy
20-day SMA: 50.4 Buy
50-day SMA: 49.88 Buy
200-day SMA: 44.87 Buy
8-day EMA: 49.16 Buy
20-day EMA: 49.72 Buy
50-day EMA: 49.41 Buy
200-day EMA: 41.75 Buy

PHAT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.03 Sell
20-day SMA: 11.06 Sell
50-day SMA: 14.52 Sell
200-day SMA: 12.22 Sell
8-day EMA: 9.11 Sell
20-day EMA: 10.78 Sell
50-day EMA: 13.08 Sell
200-day EMA: 12.68 Sell

Janux Therapeutics Earnings Growth & JANX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.91 per share.

Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.64 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.00 per share, and an increase next year of $1.26 per share.

Janux Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Phathom Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):